中药治疗慢性疲劳综合征的系统评价与Meta分析
结果显示中药可降低疲劳量表等多项评分并提高有效率,未报告严重不良事件,但纳入研究方法学质量普遍不高,结论需谨慎解读。
要点
- 中药治疗慢性疲劳综合征可降低疲劳量表评分(WMD: -1.77)。
- 中药可提高临床有效率(RR=1.41)并改善免疫球蛋白水平。
- 纳入研究未报告严重不良事件,但方法学质量普遍不高。
核心结论
- 中药治疗慢性疲劳综合征似乎有效且安全,但因纳入研究报告质量较差,结果应谨慎解读。
研究设计与样本
- 系统评价与Meta分析检索9个电子数据库,检索时间从建库至2022年5月。
- 由两名评价员独立筛选研究、提取数据并评估偏倚风险,使用Stata 12.0软件进行Meta分析。
主要发现
- 中药可降低疲劳量表评分(WMD: -1.77;95%CI: -1.96至-1.57;p < 0.001)。
- 中药可降低疲劳评估量表评分(WMD: -15.75;95%CI: -26.89至-4.61;p < 0.01)。
- 中药可降低心理状态自评量表评分(WMD: -9.72;95%CI: -12.26至-7.18;p < 0.001)。
- 中药可降低焦虑自评量表评分(WMD: -7.07;95%CI: -9.96至-4.19;p < 0.001)和抑郁自评量表评分(WMD: -5.45;95%CI: -6.82至-4.08;p < 0.001)。
- 中药可提高临床有效率(RR=1.41;95%CI: 1.33至1.49;p < 0.001),但自然杀伤细胞水平无显著变化。
关键数值与推荐
- 疲劳量表评分降低(WMD: -1.77;95%CI: -1.96至-1.57;p < 0.001)。
- 疲劳评估量表评分降低(WMD: -15.75;95%CI: -26.89至-4.61;p < 0.01)。
- 心理状态自评量表评分降低(WMD: -9.72;95%CI: -12.26至-7.18;p < 0.001)。
- 焦虑自评量表评分降低(WMD: -7.07;95%CI: -9.96至-4.19;p < 0.001),抑郁自评量表评分降低(WMD: -5.45;95%CI: -6.82至-4.08;p < 0.001)。
- 临床有效率提高(RR=1.41;95%CI: 1.33至1.49;p < 0.001),免疫球蛋白A(WMD: 0.30;95%CI: 0.20至0.41;p < 0.001)、G(WMD: 1.74;95%CI: 0.87至2.62;p < 0.001)、M(WMD: 0.21;95%CI: 0.14至0.29;p < 0.001)改善。
临床怎么用
- 中药可作为慢性疲劳综合征的潜在治疗选择,但需结合患者具体情况谨慎使用。
- 临床决策时应考虑纳入研究方法学质量不高,疗效证据强度有限。
- 未来需更多国际多中心、双盲、设计良好的随机对照试验验证。
局限性
- 纳入的随机对照试验方法学质量普遍不高。
- 研究报告质量较差,导致结果解释需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objectives: This meta-analysis aimed to assess the effectiveness and safety of Chinese herbal medicine (CHM) in treating chronic fatigue syndrome (CFS). Methods: Nine electronic databases were searched from inception to May 2022. Two reviewers screened studies, extracted the data, and assessed the risk of bias independently. The meta-analysis was performed using the Stata 12.0 software. Results: Eighty-four RCTs that explored the efficacy of 69 kinds of Chinese herbal formulas with various dosage forms (decoction, granule, oral liquid, pill, ointment, capsule, and herbal porridge), involving 6,944 participants were identified. This meta-analysis showed that the application of CHM for CFS can decrease Fatigue Scale scores (WMD: -1.77; 95%CI: -1.96 to -1.57; p < 0.001), Fatigue Assessment Instrument scores (WMD: -15.75; 95%CI: -26.89 to -4.61; p < 0.01), Self-Rating Scale of mental state scores (WMD: -9.72; 95%CI:-12.26 to -7.18; p < 0.001), Self-Rating Anxiety Scale scores (WMD: -7.07; 95%CI: -9.96 to -4.19; p < 0.001), Self-Rating Depression Scale scores (WMD: -5.45; 95%CI: -6.82 to -4.08; p < 0.001), and clinical symptom scores (WMD: -5.37; 95%CI: -6.13 to -4.60; p < 0.001) and improve IGA (WMD: 0.30; 95%CI: 0.20-0.41; p < 0.001), IGG (WMD: 1.74; 95%CI: 0.87-2.62; p < 0.001), IGM (WMD: 0.21; 95%CI: 0.14-0.29; p < 0.001), and the effective rate (RR = 1.41; 95%CI: 1.33-1.49; p < 0.001). However, natural killer cell levels did not change significantly. The included studies did not report any serious adverse events. In addition, the methodology quality of the included RCTs was generally not high. Conclusion: Our study showed that CHM seems to be effective and safe in the treatment of CFS. However, given the poor quality of reports from these studies, the results should be interpreted cautiously. More international multi-centered, double-blinded, well-designed, randomized controlled trials are needed in future research. Systematic Review Registration: [https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022319680], identifier [CRD42022319680].
引用
- Zhang Y, Jin F, Wei X, et al. Chinese herbal medicine for the treatment of chronic fatigue syndrome: A systematic review and meta-analysis. Front Pharmacol. 2022. PMID: 36249791. doi:10.3389/fphar.2022.958005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。